Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus

American Heart Journal

Volumn 149, Issue 4, 2005, Pages 632-636

  Vrtovec, Matjaz ^a   Vrtovec, Bojan ^a   Briski, Alenka ^a   Kocijancic, Andreja ^a   Anderson, Richard A ^b   Radovancevic, Branislav ^c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM PICOLINATE; PLACEBO;

ARTICLE; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAPHY MONITORING; HEART BEAT; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL;

EID: 17044363062     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.07.021     Document Type: Article

References (15)

1. B. Linnemann, and H.U. Janka Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study Exp. Clin. Endocrinol. Diabetes 111 2003 215 222
2. P.M. Okin, R.B. Devereux, and E.T. Lee Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the Strong Heart Study Diabetes 53 2004 434 440
3. C.R. Cardoso, G.F. Salles, and W. Deccache QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus Stroke 34 2003 2187 2194
4. J.M. Dekker, E.J. Feskens, and E.G. Schouten QT duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study Diabetes 45 1996 376 380
5. D.S. Kim, T.W. Kim, and I.K. Park Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats Metabolism 51 2002 589 594
6. R.A. Anderson, N. Cheng, and N.A. Bryden Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes Diabetes 46 1997 1786 1791
7. J.M. Hayden, and P.D. Reaven Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors Curr. Opin. Lipidol. 11 2000 519 528
8. M. Simonoff Chromium deficiency and cardiovascular risk Cardiovasc. Res. 18 1984 591 596
9. L. Toivonen More light on QT interval measurement Heart 87 2002 193 194
10. J.M. Dekker, E.J.M. Feskens, and E.G. Schouten QTc duration is associated with levels of insulin and glucose tolerance Diabetes 45 1996 376 380
11. A. Gastaldelli, M. Emdin, and F. Conforti Insulin prolongs the QTc interval in humans Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 2000 R2022 R2025
12. S. Zhou, J.M. Cao, and Z.D. Tebb Modulation of QT interval by cardiac sympathetic nerve sprouting and the mechanisms of ventricular arrhythmia in a canine model of sudden cardiac death J. Cardiovasc. Electrophysiol. 12 2001 1068 1073
13. N. Cheng, X. Zhu, and S. Hongli Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium J. Trace Elem. Exp. Med. 12 1999 55 60
14. S.K. Jain, and K. Kannan Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured U937 monocytes Biochem. Biophys. Res. Commun. 289 2001 687 691
15. A.P. Yazdanbakhsh, B. Vrtovec, and B. Radovancevic Increased levels of high-sensitivity C-reactive protein are associated with a longer QTc interval in apparently healthy subjects J. Am. Coll. Cardiol. 41 2003 111A 112A